Abstract
Objectives
Late presentation of HIV continues to undermine advances in the management of HIV. Opportunities to detect HIV at an earlier stage are often missed. Current estimates suggest that undiagnosed individuals comprise approximately one quarter of all people in the western world living with HIV. ‘Testing-and-treating’ this group has been proposed as a means to curb the HIV epidemic. In this study we assessed the characteristics of individuals newly diagnosed with HIV, and their utilisation of healthcare services in Ireland prior to their diagnosis.
Methods
A retrospective review was undertaken of all patients newly diagnosed with HIV over a 27-month period. Patient demographics were recorded, as were details of healthcare contacts in the year preceding diagnosis. Individuals detected via screening of recent immigrants/asylum seekers were excluded.
Results
In the period studied 114 patients received a new diagnosis of HIV, 59 met inclusion criteria. The majority (54 %) fulfilled the European consensus definition for late presenters (CD4 < 350 cells/µl). ‘Late presenters’ were significantly more likely to be symptomatic at diagnosis (OR = 4.62; 95 % CI 1.45–14.67; p = 0.015), diagnosed by acute tertiary hospital services (p = 0.015), and 56 % reported heterosexual mode of acquisition (OR = 2.12; 95 % CI 0.73–6.16; p = 0.19). Patients detected via screening had significantly higher CD4 counts at diagnosis compared with those diagnosed due to symptoms (Median CD4 422 cells/µl; IQR 285–594 vs. 142 cells/µl; IQR 62–333; p = 0.0007). ‘Symptomatic’ patients were significantly more likely to report prior healthcare contacts (OR 4.71; 95 % CI 1.32–16.79; p = 0.013).
Conclusion
Current screening activities are inadequate. Unfortunately newly diagnosed HIV patients continue to be symptomatic, at advanced stages of disease, to acute hospital services. Heterosexual groups in particular are at risk for late detection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Granich R, Crowley S, Vitoria M et al (2010) Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS 5(4):298–304
Granich RM, Gilks CF, Dye C, De Kock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373(9657):48–57
Cambiano V, Rodger AJ, Phillips AN (2011) ‘Test-and-treat’: the end of the HIV epidemic? Curr Opin Infect Dis 24(1):19–26
Montaner JS, Lima VD, Barrios R et al (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376(9740):532–539
Glynn MK, Rhodes P. What is really happening with HIV trends in the United States? Modeling the national epidemic. Presented at: National HIV Prevention Conference, Atlanta, GA, USA, 12–15 June 2005 [Abstract T1-B11-13]
CDC (2008) HIV Prevalence estimates: United States, 2006. MMWR 57(39):1073–1076
Health Protection Agency (2008) HIV in the United Kingdom: 2008 Report. Published Nov 2008
CDC (2009) HIV/AIDS surveillance report 2007, vol 19. US Department of Health and Human Services, CDC, Atlanta
Marks G, Crepaz N, Jannssen RS (2006) Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20(10):1447–1450
Antinori A, Coenen T, Costagiola D, European Late Presenter Consensus Working Group et al (2011) Late presentation of HIV infection: a consensus definition. HIV Med 2(1):61–64
Johnson M, Sabin C, Girardi E (2010) Definition and epidemiology of late presentation in Europe. Antivir Ther 15(1):3–8
Sullivan AK, Curtis H, Sabin CA, Johnson MA (2005) Newly diagnosed HIV infections: review in UK and Ireland. BMJ 330(7503):1301–1302
Battegay M, Fluckiger U, Hirschel B, Furrer H (2007) Late presentation of HIV-infected individuals. Antivir Ther 12(6):841–851
Nidaye B, Salleron J, Vincent A et al (2011) Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997–2007. BMC Infect Dis 11:11
Wolbers M, Bucher H, Furrer H et al (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 9:397–405
Zoufaly A, an der Heiden M, Marius U et al (2012) Late presentation for HIV diagnosis and care in Germany. HIV Med 13(3):172–181
d’Arminio Monforte A, Cozzi-Lepri A, Girardi E et al (2011) Late presenters in new HIV diagnoses from an Italian Cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther 16(7):1103–1112
Burns FM, Johnson AM, Nazroo J et al (2008) Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 22(1):115–122
Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH (2004) Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 19(4):349–356
McDonald EA, Currie MJ, Bowden FJ (2006) Delayed diagnosis of HIV: missed opportunities and triggers for testing in the Australian capital territory. Sex Health 3(4):291–295
Health protection surveillance centre. HIV and AIDS in Ireland 2011. http://www.hpsc.ie/hpsc/A-Z/HIVSTIs/HIVandAIDS/SurveillanceReports/File,13068,en.pdf. May 2012. Last accessed July 2012
Philips A, Pezzotti P (2004) CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naïve individuals and those treated in the monotherapy era. AIDS 18:51–58
Egger M, May M, Chene G et al (2002) Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360(9327):119–129
Sabin CA, Smith CJ, Gumley H et al (2004) Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 18(16):2145–2151
Pinkerton SD, Holtgrave DR, Galletly CL (2008) Infections prevented by increasing HIV serostatus awareness in the United States 2001–2004. J Acquir Immune Defic Syndr 47(3):354–357
Sanders GD, Bayoumi AM, Sundarum V et al (2005) Cost effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352(6):570–585
Paltiel AD, Walensky RP, Schackerman BR et al (2005) Expanded screening for HIV in the United States—an analysis of cost-effectiveness. N Eng J Med 352(6):S86–S95
CDC (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 55(RR-14):1–17
Paltiel AD (2006) Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission and costs. Ann Intern Med 145(11):797–806
Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ (2006) Risk based human immunodeficiency virus testing fails to detect majority of HIV-infected individuals in medical care settings. Sex Transm Dis 33(5):329–333
Acknowledgments
We acknowledge the participating patients, and the staff of the department of Infectious Diseases and Tropical Medicine in Beaumont hospital, Dublin.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D, O., Ebrahim, M., Egli, A. et al. Late presentation of HIV despite earlier opportunities for detection, experience from an Irish Tertiary Referral Institution. Ir J Med Sci 182, 389–394 (2013). https://doi.org/10.1007/s11845-012-0898-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-012-0898-2